Quorum Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-05-2024
- Paid Up Capital ₹ 0.10 M
as on 15-05-2024
- Company Age 15 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 4.55%
(FY 2020)
- Profit 8.29%
(FY 2020)
- Ebitda -4.00%
(FY 2020)
- Net Worth 0.23%
(FY 2020)
- Total Assets 0.24%
(FY 2020)
About Quorum Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amar Chitrakar and Suparna Chitrakar serve as directors at the Company.
- CIN/LLPIN
U24100DL2009PTC193814
- Company No.
193814
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Sep 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
East Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Quorum Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amar Chitrakar  | Director | 03-Feb-2024 | Current |
| Suparna Chitrakar | Director | 03-Feb-2024 | Current |
Financial Performance and Corporate Structure Insights of Quorum Biotech.
Quorum Biotech Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 4.55% increase. The company also saw a slight improvement in profitability, with a 8.29% increase in profit. The company's net worth moved up by a moderate rise of 0.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quorum Biotech?
In 2019, Quorum Biotech had a promoter holding of 99.99% and a public holding of 0.01%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Abhigam Tradecom Private LimitedActive 20 years 11 monthsAmar Chitrakar and Suparna Chitrakar are mutual person
- Feastlo Enterprises Private LimitedActive 21 years 5 months
Amar Chitrakar and Suparna Chitrakar are mutual person
- Khatushyam Multitrades Private LimitedActive 3 years 4 months
Amar Chitrakar and Suparna Chitrakar are mutual person
- Pearl Infraprojects Private LimitedActive 14 years 9 months
Amar Chitrakar and Suparna Chitrakar are mutual person
- Glee Tradex Private LimitedActive 13 years 9 months
Amar Chitrakar and Suparna Chitrakar are mutual person
- Sugriva Jankalyan FoundationActive 7 years 9 months
Amar Chitrakar and Suparna Chitrakar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Quorum Biotech?
Unlock and access historical data on people associated with Quorum Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quorum Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quorum Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
